Clinical Trial Update: Clinical Study of 12-week Trehalose Intake in Patients With Fatty Liver Disease [NA]

View source ↗

Summary

A clinical trial evaluating 12 weeks of trehalose intake in patients with non-alcoholic fatty liver disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Trehalose (trehalose)

Snippet

Sponsor: Samsung Medical Center | Conditions: Non-alcoholic Fatty Liver | NA | Status: COMPLETED